Den norske Eterfabrikk
1900
FOUNDED
M&A
STATUS
Buyout/LBO
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Operator of a pharmaceutical company. The company is engaged in developing and marketing of prescription drugs, OTC, cosmetics and chemicals. Its products include Methadone (substitution), STOP24 (sweat treatment), Malation (lice treatment), plaster remover, wart funds and ether.
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
- PO Box 10 Bøler
- 0620 Oslo
- Norway
Den norske Eterfabrikk Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Den norske Eterfabrikk‘s full profile, request access.
Request full access to PitchBook